RDUS · Insider Trading
Radius Recycling, Inc. Class A Common Stock
Every open-market purchase and sale reported by RDUS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-08-15 | Chhaya Shah | Chief Business Officer | D | −94,645 | −$946.45K |
| 2022-08-15 | Elizabeth Messersmith | Senior Vice President | D | −70,000 | −$700.00K |
| 2022-08-15 | Danielle Holtschlag | Vice President, Sales | D | −25,000 | −$250.00K |
| 2022-08-15 | Jennifer Jarrett | Director | D | −30,000 deriv. | — |
| 2022-08-15 | Susan Vissers Lisa | Director | D | −30,000 deriv. | — |
| 2022-08-15 | Sean Murphy | Director | U | −5,500 | −$55.00K |
| 2022-08-15 | Cathy Friedman | Director | D | −26,800 | −$268.00K |
| 2022-08-15 | Owen Hughes | Director | U | −21,650 | −$216.50K |
| 2022-08-15 | Jean Pierre Garnier | Director | MIXED | −32,300 | −$323.00K |
| 2022-08-15 | Andrew C. Von Eschenbach | Director | D | −5,500 | −$55.00K |
| 2022-08-15 | G. Kelly Martin | CEO and President | D | −75,000 | −$750.00K |
| 2022-08-15 | Willard H Dere | Director | MIXED | −23,195 | −$231.95K |
| 2022-08-15 | Machelle Sanders | Director | D | −5,500 | −$55.00K |
| 2022-08-12 | Rubric Capital Management LP | 10%+ Owner | Buy | +1,678,954 | +$16.91M |
| 2022-08-11 | Rubric Capital Management LP | 10%+ Owner | Buy | +4,012 | +$40.40K |
| 2022-05-20 | Susan Vissers Lisa | Director | A | +30,000 deriv. | — |
| 2022-05-20 | Jennifer Jarrett | Director | A | +30,000 deriv. | — |
| 2022-05-20 | BB BIOTECH AG | 10%+ Owner | Buy | +477,824 | +$2.66M |
| 2022-03-17 | Mark William Conley | VP, Chief Financial Officer | A | +50,000 | — |
| 2022-02-25 | G. Kelly Martin | CEO and President | A | +75,000 | — |
| 2022-02-23 | G. Kelly Martin | CEO and President | A | +960,000 | — |
| 2022-01-25 | Chhaya Shah | Chief Business Officer | A | +65,000 | — |
| 2022-01-25 | Danielle Holtschlag | Vice President, Sales | A | +25,000 | — |
| 2022-01-25 | Owen Hughes | Director | A | +5,500 | — |
| 2022-01-25 | Willard H Dere | Director | A | +5,500 | — |
| 2022-01-25 | Sean Murphy | Director | A | +5,500 | — |
| 2022-01-25 | Andrew C. Von Eschenbach | Director | A | +5,500 | — |
| 2022-01-25 | Jean Pierre Garnier | Director | A | +5,500 | — |
| 2022-01-25 | Machelle Sanders | Director | A | +5,500 | — |
| 2022-01-25 | Steven Helwig | Principal Financial Officer | A | +15,000 | — |
| 2022-01-25 | Cathy Friedman | Director | A | +5,500 | — |
| 2022-01-07 | Target N V Biotech | 10%+ Owner | Buy | +550,000 | +$3.47M |
| 2021-12-16 | Rubric Capital Management LP | 10%+ Owner | Buy | +146,685 | +$1.04M |
| 2021-12-15 | Rubric Capital Management LP | 10%+ Owner | Buy | +462,238 | +$3.19M |
| 2021-12-10 | Rubric Capital Management LP | 10%+ Owner | Buy | +1,593,506 | +$12.02M |
| 2021-10-18 | Danielle Holtschlag | Vice President, Sales | A | +50,000 deriv. | — |
| 2021-10-01 | BB BIOTECH AG | 10%+ Owner | Buy | +100,000 | +$1.29M |
| 2021-09-24 | BB BIOTECH AG | 10%+ Owner | Buy | +150,000 | +$1.84M |
| 2021-09-23 | Chhaya Shah | Chief Business Officer | A | +10,000 | — |
| 2021-08-26 | Steven Helwig | Principal Financial Officer | A | +5,125 | — |
| 2021-03-24 | G. Kelly Martin | CEO and President | A | +460,000 deriv. | — |
| 2021-03-09 | James George Chopas | Principal Finance Accounting | Sell | −370 | −$7.73K |
| 2021-02-26 | Sal Grausso | Chief Commercial Officer | Sell | −1,322 | −$25.03K |
| 2021-02-23 | Cathy Friedman | Director | A | +5,500 | — |
| 2021-02-23 | G. Kelly Martin | CEO and President | A | +460,000 deriv. | — |
| 2021-02-23 | Sean Murphy | Director | A | +5,500 | — |
| 2021-02-23 | Owen Hughes | Director | A | +5,500 | — |
| 2021-02-23 | Sal Grausso | Chief Commercial Officer | A | +60,000 deriv. | — |
| 2021-02-23 | James George Chopas | Principal Finance Accounting | A | +20,000 deriv. | — |
| 2021-02-23 | Willard H Dere | Director | A | +5,500 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the RDUS quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.